Jonathan Jacinto - Concepedia

Author

Jonathan Jacinto

Xencor (United States)ORCID

Also Known As

J. Jacinto, Jonathan Jacinto, Jonathan M. Jacinto

Publications

634

Citations

H-Index

Concepts

All Affiliations

Xencor (United States)

About

Jonathan Jacinto is an author at Xencor (United States) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	467
2	Engineering	2	2	173
3	Natural Sciences	1	1	56
4	Allergy	1	1	87
5	Biochemistry	1	1	56

Jonathan Jacinto

Publications

630

Citations

H-Index

Page 1

	Year	Citations
Combining computational and experimental screening for rapid optimization of protein properties Robert J. Hayes, Jörg Bentzien, Marian Y. Hwang, Proceedings of the National Academy of Sciences	2002	130
A molecular immunology approach to antibody humanization and functional optimization Greg A. Lazar, John R. Desjarlais, Jonathan Jacinto, Molecular Immunology EngineeringMedicineImmunoengineeringImmunologyAntibody Screening	2006	107
A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens Gregory L. Moore, Cristina Bautista, Erik Pong, mAbs ImmunologyImmunodominanceAntigen ProcessingImmunotherapeuticsImmunotherapy	2011	101
Clinical link between MHC class II haplotype and interferon-beta (IFN-β) immunogenicity Maria D.F.S. Barbosa, Jost Vielmetter, Seung Y. Chu, Clinical Immunology HistocompatibilityImmunogeneticsAllergyHla ImmunogeneticsImmunology	2005	87
A robust heterodimeric Fc platform engineered for efficient development of bispecific antibodies of multiple formats Gregory L. Moore, Matthew J. Bernett, Rumana Rashid, Methods EngineeringImmunotherapeuticsBiomedical EngineeringAnalytical UltracentrifugationImmunotherapy	2018	66
Development of a cytokine analog with enhanced stability using computational ultrahigh throughput screening Peizhi Luo, Robert J. Hayes, Cheryl Chan, Protein Science Enhanced StabilityShelf LifeImmunologyBovine G-csfInflammation	2002	56
Engineering Fully Human Monoclonal Antibodies from Murine Variable Regions Matthew J. Bernett, Sher Karki, Gregory L. Moore, Journal of Molecular Biology Immunocytochemical TechniqueMedicineMurine Variable RegionsImmunologyAntibody Screening	2010	50
A Humanized Anti-CD30 Monoclonal Antibody, XmAb™2513, with Enhanced In Vitro Potency Against CD30-Positive Lymphomas Mediated by High Affinity Fc-Receptor Binding. Philip W. Hammond, Omid Vafa, Jonathan Jacinto, Blood	2005	18
A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti–PD-1 and CD3 T-cell Engager Immunotherapies Gregory L. Moore, Veronica G. Zeng, Juan E. Diaz, Molecular Cancer Therapeutics	2024	15

Page 1